A citation-based method for searching scientific literature

Fariba Behbod, Frances S Kittrell, Heather LaMarca, David Edwards, Sofia Kerbawy, Jessica C Heestand, Evelin Young, Purna Mukhopadhyay, Hung-Wen Yeh, D Craig Allred, Min Hu, Kornelia Polyak, Jeffrey M Rosen, Daniel Medina. Breast Cancer Res 2009
Times Cited: 141







List of co-cited articles
666 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.
George Sflomos, Valerian Dormoy, Tauno Metsalu, Rachel Jeitziner, Laura Battista, Valentina Scabia, Wassim Raffoul, Jean-Francois Delaloye, Assya Treboux, Maryse Fiche,[...]. Cancer Cell 2016
111
34

MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.
F R Miller, S J Santner, L Tait, P J Dawson. J Natl Cancer Inst 2000
218
29

Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model.
Kelli Elizabeth Valdez, Fang Fan, William Smith, D Craig Allred, Daniel Medina, Fariba Behbod. J Pathol 2011
54
51

Regulation of in situ to invasive breast carcinoma transition.
Min Hu, Jun Yao, Danielle K Carroll, Stanislawa Weremowicz, Haiyan Chen, Daniel Carrasco, Andrea Richardson, Shelia Violette, Tatiana Nikolskaya, Yuri Nikolsky,[...]. Cancer Cell 2008
363
17

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Richard M Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L Baehner, Tea Fevr, Laura Clark, Nora Bayani, Jean-Philippe Coppe, Frances Tong,[...]. Cancer Cell 2006
14

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
14

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.
Yoko S DeRose, Guoying Wang, Yi-Chun Lin, Philip S Bernard, Saundra S Buys, Mark T W Ebbert, Rachel Factor, Cindy Matsen, Brett A Milash, Edward Nelson,[...]. Nat Med 2011
630
12

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Peter Eirew, Adi Steif, Jaswinder Khattra, Gavin Ha, Damian Yap, Hossein Farahani, Karen Gelmon, Stephen Chia, Colin Mar, Adrian Wan,[...]. Nature 2015
414
11

The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours.
Elodie Richard, Thomas Grellety, Valerie Velasco, Gaetan MacGrogan, Hervé Bonnefoi, Richard Iggo. J Pathol 2016
21
52

Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Tanya D Russell, Sonali Jindal, Samiat Agunbiade, Dexiang Gao, Megan Troxell, Virginia F Borges, Pepper Schedin. Am J Pathol 2015
37
27


Patient-derived xenograft models: an emerging platform for translational cancer research.
Manuel Hidalgo, Frederic Amant, Andrew V Biankin, Eva Budinská, Annette T Byrne, Carlos Caldas, Robert B Clarke, Steven de Jong, Jos Jonkers, Gunhild Mari Mælandsmo,[...]. Cancer Discov 2014
907
9

Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts.
P Cottu, E Marangoni, F Assayag, P de Cremoux, A Vincent-Salomon, Ch Guyader, L de Plater, C Elbaz, N Karboul, J J Fontaine,[...]. Breast Cancer Res Treat 2012
60
15

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
Xiaomei Zhang, Sofie Claerhout, Aleix Prat, Lacey E Dobrolecki, Ivana Petrovic, Qing Lai, Melissa D Landis, Lisa Wiechmann, Rachel Schiff, Mario Giuliano,[...]. Cancer Res 2013
297
9

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
202
8

Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Sangjun Lee, Sheila Stewart, Iris Nagtegaal, Jingqin Luo, Yun Wu, Graham Colditz, Dan Medina, D Craig Allred. Cancer Res 2012
106
8

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
Elgene Lim, François Vaillant, Di Wu, Natasha C Forrest, Bhupinder Pal, Adam H Hart, Marie-Liesse Asselin-Labat, David E Gyorki, Teresa Ward, Audrey Partanen,[...]. Nat Med 2009
950
8


Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
8

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
7

Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
387
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
7

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
214
7

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Szeman Ruby Chan, William Vermi, Jingqin Luo, Laura Lucini, Charles Rickert, Amy M Fowler, Silvia Lonardi, Cora Arthur, Larry Jt Young, David E Levy,[...]. Breast Cancer Res 2012
121
7

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
7

MCF10AT: a model for the evolution of cancer from proliferative breast disease.
P J Dawson, S R Wolman, L Tait, G H Heppner, F R Miller. Am J Pathol 1996
240
7

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Serena Nik-Zainal, Helen Davies, Johan Staaf, Manasa Ramakrishna, Dominik Glodzik, Xueqing Zou, Inigo Martincorena, Ludmil B Alexandrov, Sancha Martin, David C Wedge,[...]. Nature 2016
7

Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.
Maryse Fiche, Valentina Scabia, Patrick Aouad, Laura Battista, Assia Treboux, Athina Stravodimou, Khalil Zaman, Valerian Dormoy, Ayyakkannu Ayyanan, George Sflomos,[...]. J Pathol 2019
17
41

Reconstruction of functionally normal and malignant human breast tissues in mice.
Charlotte Kuperwasser, Tony Chavarria, Min Wu, Greg Magrane, Joe W Gray, Loucinda Carey, Andrea Richardson, Robert A Weinberg. Proc Natl Acad Sci U S A 2004
571
6

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
132
6

Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
Christopher Jedeszko, Bernadette C Victor, Izabela Podgorski, Bonnie F Sloane. Cancer Res 2009
83
7

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
6

Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
624
6


Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.
Shunqiang Li, Dong Shen, Jieya Shao, Robert Crowder, Wenbin Liu, Aleix Prat, Xiaping He, Shuying Liu, Jeremy Hoog, Charles Lu,[...]. Cell Rep 2013
408
6

Patient-derived xenograft models of breast cancer and their predictive power.
James R Whittle, Michael T Lewis, Geoffrey J Lindeman, Jane E Visvader. Breast Cancer Res 2015
177
6


Mechanisms of endocrine resistance in breast cancer.
C Kent Osborne, Rachel Schiff. Annu Rev Med 2011
741
6

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Jason I Herschkowitz, Karl Simin, Victor J Weigman, Igor Mikaelian, Jerry Usary, Zhiyuan Hu, Karen E Rasmussen, Laundette P Jones, Shahin Assefnia, Subhashini Chandrasekharan,[...]. Genome Biol 2007
817
6

Xenograft model of progressive human proliferative breast disease.
F R Miller, H D Soule, L Tait, R J Pauley, S R Wolman, P J Dawson, G H Heppner. J Natl Cancer Inst 1993
187
6

p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.
C Lodillinsky, E Infante, A Guichard, R Chaligné, L Fuhrmann, J Cyrta, M Irondelle, E Lagoutte, S Vacher, H Bonsang-Kitzis,[...]. Oncogene 2016
58
10

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Lacey E Dobrolecki, Susie D Airhart, Denis G Alferez, Samuel Aparicio, Fariba Behbod, Mohamed Bentires-Alj, Cathrin Brisken, Carol J Bult, Shirong Cai, Robert B Clarke,[...]. Cancer Metastasis Rev 2016
125
6

Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Hanan S Elsarraj, Yan Hong, Kelli E Valdez, Whitney Michaels, Marcus Hook, William P Smith, Jeremy Chien, Jason I Herschkowitz, Melissa A Troester, Moriah Beck,[...]. Breast Cancer Res 2015
33
18

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
Larry R Tait, Robert J Pauley, Steven J Santner, Gloria H Heppner, Henry H Heng, Janusz W Rak, Fred R Miller. Int J Cancer 2007
56
8

Xenograft models of premalignant breast disease.
F R Miller. J Mammary Gland Biol Neoplasia 2000
86
5

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
80
6

Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
S J Santner, P J Dawson, L Tait, H D Soule, J Eliason, A N Mohamed, S R Wolman, G H Heppner, F R Miller. Breast Cancer Res Treat 2001
308
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.